Skip to Content
Merck
CN
  • Protocol to generate cardiac pericytes from human induced pluripotent stem cells.

Protocol to generate cardiac pericytes from human induced pluripotent stem cells.

STAR protocols (2023-04-29)
Mengcheng Shen, Shane Rui Zhao, Yaser Khokhar, Li Li, Yang Zhou, Chun Liu, Joseph C Wu
ABSTRACT

Cardiac pericytes are a critical yet enigmatic cell type within the coronary microvasculature. Since primary human cardiac pericytes are not readily accessible, we present a protocol to generate them from human induced pluripotent stem cells (hiPSCs). Our protocol involves several steps, including the generation of intermediate cell types such as mid-primitive streak, lateral plate mesoderm, splanchnic mesoderm, septum transversum, and epicardium, before deriving cardiac pericytes. With hiPSC-derived cardiac pericytes, researchers can decipher the mechanisms underlying coronary microvascular dysfunction. For complete details on the use and execution of this protocol, please refer to Shen et al.1.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Chondroitin Sulfate Proteoglycan Antibody, clone 9.2.27, clone 9.2.27, Chemicon®, from mouse
Sigma-Aldrich
Monoclonal Anti-Calponin antibody produced in mouse, clone hCP, ascites fluid
Sigma-Aldrich
Anti-Actin, α-Smooth Muscle antibody, Mouse monoclonal, clone 1A4, purified from hybridoma cell culture